Worldwide trends in asthma mortality
- PMID: 1684522
Worldwide trends in asthma mortality
Abstract
Statistics for deaths from asthma yield widely variable mortality rates between countries. Validation studies show significant inaccuracies in certification of cause of death in older subjects, and probable underreporting of asthma deaths in some countries, explaining some of the international differences noted. The introduction of the ninth revision of the World Health Organisation International Classification of Diseases brought a step increase in reported asthma mortality rates in 1979, but the last decade has seen a gradual increase in mortality rates in many countries, especially in young people, not explained by this change in code. Diagnostic transfer does not adequately explain these increases. Individuals at risk of death from asthma are more likely to be non-caucasian, non-compliant, and young, with a history of previous life-threatening episodes, hospital admissions, and precipitous attacks. Studies of circumstances of death have emphasized overreliance on beta-agonists and underuse of corticosteroids as two primary deficiencies in management, but there remains debate about the causality of the association between increased asthma mortality and increased usage of beta-agonists. The gradual increase in asthma mortality seen in New Zealand over the last 40 years, with episodic increases in the rising baseline, together with similar but more gradual changes in other countries, raises concerns about whether current treatment practices may adversely affect asthma severity and mortality. Further studies are required to validate asthma mortality statistics, and to establish causation of deaths.
Similar articles
-
Why are deaths from asthma increasing?Eur J Respir Dis Suppl. 1986;147:175-81. Eur J Respir Dis Suppl. 1986. PMID: 2876911 Review.
-
Trends in mortality from bronchial asthma in Switzerland, 1969-1993.Rev Epidemiol Sante Publique. 1996 Apr;44(2):155-61. Rev Epidemiol Sante Publique. 1996. PMID: 8693172
-
Asthma mortality in New Zealand: a two year national study.N Z Med J. 1985 Apr 24;98(777):271-5. N Z Med J. 1985. PMID: 2859567
-
Deaths with asthma in France, 2000-2005: a multiple-cause analysis.J Asthma. 2009 May;46(4):402-6. doi: 10.1080/02770900902795553. J Asthma. 2009. PMID: 19484678
-
Changing patterns in asthma morbidity and mortality.J Investig Allergol Clin Immunol. 1995 Mar-Apr;5(2):66-72. J Investig Allergol Clin Immunol. 1995. PMID: 7655702 Review.
Cited by
-
Drug treatment of asthma in the 1990s: achievements and new strategies.Drugs. 1999 Jan;57(1):1-8. doi: 10.2165/00003495-199957010-00001. Drugs. 1999. PMID: 9951947 Review.
-
The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology.Drug Saf. 1994 Oct;11(4):259-83. doi: 10.2165/00002018-199411040-00005. Drug Saf. 1994. PMID: 7848546 Review.
-
Measured bronchodilator use in preschool children with asthma.BMJ. 1995 May 6;310(6988):1161-4. doi: 10.1136/bmj.310.6988.1161. BMJ. 1995. PMID: 7767149 Free PMC article.
-
Effect of different monotherapies on serum nitric oxide and pulmonary functions in children with mild persistent asthma.Arch Med Sci. 2010 Dec;6(6):919-25. doi: 10.5114/aoms.2010.19302. Epub 2010 Dec 29. Arch Med Sci. 2010. PMID: 22427767 Free PMC article.
-
Active-Ingredient Screening and Synergistic Action Mechanism of Shegan Mixture for Anti-Asthma Effects Based on Network Pharmacology in a Mouse Model of Asthma.Drug Des Devel Ther. 2021 Apr 29;15:1765-1777. doi: 10.2147/DDDT.S288829. eCollection 2021. Drug Des Devel Ther. 2021. PMID: 33953545 Free PMC article.